Your browser doesn't support javascript.
loading
The HO-1-expressing bone mesenchymal stem cells protects intestine from ischemia and reperfusion injury.
Yan, Xue-Tao; Cheng, Xiao-Li; He, Xiang-Hu; Zheng, Wen-Zhong; Xiao-Fang, Yuan; Hu, Chen.
Afiliação
  • Yan XT; Department of Anesthesiology, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518102, China. yanxuetaowu@outlook.com.
  • Cheng XL; Department of Anesthesiology, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518102, China.
  • He XH; Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
  • Zheng WZ; Department of Anesthesiology, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518102, China.
  • Xiao-Fang Y; Department of Anesthesiology, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518102, China.
  • Hu C; Department of Anesthesiology, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518102, China.
BMC Gastroenterol ; 19(1): 124, 2019 Jul 12.
Article em En | MEDLINE | ID: mdl-31299915
ABSTRACT

BACKGROUND:

Bone mesenchymal stromal cells (BMSC) showed protective potential against intestinal ischemia. Oxygenase-1(HO-1) could alleviate oxidative stress. In the present study, we constructed HO-1-expressing BMSC and detected the effects of it on survival, intestinal injury and inflammation following intestinal ischemia and reperfusion injury (I/R).

METHODS:

In this experiment, eighty adult male mice were divided into Sham, I/R, I/R + BMSC, I/R + BMSC/HO-1 groups. Mice were anesthetized and intestinal I/R model were established by temporarily occluding the superior mesenteric artery for 60 min with a non-crushing clamp. Following ischemia, the clamp was removed and the intestines were allowed for reperfusion. Prior to abdominal closure, BMSC/ HO-1 (2 × 106 cells) or BMSC (2 × 106 cells) were injected into the peritoneum of I/R mice respectively. Mice were allowed to recover for 24 h and then survival rate, intestinal injury and inflammation were determined. Reactive oxygen species (ROS) was assayed by fluorescent probe. TNFα and IL-6 were assayed by ELISA.

RESULTS:

BMSC/HO-1 increased seven day survival rate, improved intestinal injury and down-regulated inflammation after intestinal I/R when compared with sole BMSC (p < 0.05 respectively). Multiple pro-inflammatory media were also decreased following application of BMSC/HO-1, when compared with sole BMSC (p < 0.05) respectively, suggesting that BMSC /HO-1 had a better protection to intestinal I/R than BMSC therapy.

CONCLUSION:

Administration of BMSC/HO-1 following intestinal I/R, significantly improved intestinal I/R by limiting intestinal damage and inflammation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão / Transplante de Células-Tronco Mesenquimais / Heme Oxigenase-1 / Células-Tronco Mesenquimais / Enteropatias / Intestinos / Proteínas de Membrana Limite: Animals Idioma: En Revista: BMC Gastroenterol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão / Transplante de Células-Tronco Mesenquimais / Heme Oxigenase-1 / Células-Tronco Mesenquimais / Enteropatias / Intestinos / Proteínas de Membrana Limite: Animals Idioma: En Revista: BMC Gastroenterol Ano de publicação: 2019 Tipo de documento: Article